Control of in vitro neural differentiation of mesenchymal stem cells in 3D macroporous, cellulosic hydrogels
Abstract
Background: Mesenchymal stem cells (MSCs) are multipotent cells that can be induced to differentiate into multiple cell lineages, including neural cells. They are a good cell source for neural tissue-engineering applications. Cultivation of human (h)MSCs in 3D scaffolds is an effective means for the development of novel neural tissue-engineered constructs, and may serve as a promising strategy in the treatment of nerve injury. Aim: This study presents the in vitro growth and neural differentiation of hMSCs in 3D macroporous, cellulosic hydrogels. Results: The number of hMSCs cultivated in the 3D scaffolds increased by more than 14-fold after 7 days. After 2 days induction, most of the hMSCs in the 3D scaffolds were positive for nestin, a marker of neural stem cells. After 7 days induction, most of the hMSCs in the 3D scaffolds showed glial fibrillary acidic protein, tubulin or neurofilament M-positive reaction and a few hMSCs were positive for nestin. After 14 days induction, hMSCs in the 3D scaffolds could completely differentiate into neurons and glial cells. The neural differentiation of hMSCs in the 3D scaffolds was further demonstrated by real-time PCR. Conclusion: These results show that the 3D macroporous cellulosic hydrogel could be an appropriate substrate for neural differentiation of hMSCs and its possible applications in neural tissue engineering are discussed.
Bibliography
- 1 Stichel CC, Muller HW: Experimental strategies to promote axonal regeneration after traumatic central nervous system injury. Prog. Neurobiol.56(2),119–148 (1998).
- 2 Raisman G: Repair of spinal cord injury: ripples of an incoming tide, or how I spent my first 40 years in research. Spinal Cord44(7),406–413 (2006).
- 3 Czeiter E, Pal J, Kovesdi E et al.: Traumatic axonal injury in the spinal cord evoked by traumatic brain injury. J. Neurotrauma25(3),205–213 (2008).
- 4 Miller RH: The promise of stem cells for neural repair. Brain Res.1091(1),258–264 (2006).
- 5 Wilkins A, Scolding N: Protecting axons in multiple sclerosis. Mult. Scler.14(8),1013–1025 (2008).
- 6 Wong DY, Krebsbach PH, Hollister SJ: Brain cortex regeneration affected by scaffold architectures. J. Neurosurg.109(4),715–722 (2008).
- 7 Schmidt CE, Leach JB: Neural tissue engineering: strategies for repair and regeneration. Ann. Rev. Biomed. Eng.5,293–347 (2003).
- 8 Nisbet DR, Moses D, Gengenbach TR, Forsythe JS, Finkelstein DI, Horne MK: Enhancing neurite outgrowth from primary neurones and neural stem cells using thermoresponsive hydrogel scaffolds for the repair of spinal cord injury. J. Biomed. Mater. Res. A89(1),24–35 (2009).
- 9 Bruns S, Stark Y, Wieland M, Stahl F, Kasper C, Scheper T: Fast and efficient screening system for new biomaterials in tissue engineering: a model for peripheral nerve regeneration. J. Biomed. Mater. Res. A81(3),736–747 (2007).
- 10 Gage FH: Mammalian neural stem cells. Science287(5457),1433–1438 (2000).
- 11 Song HJ, Stevens CF, Gage FH: Neural stem cells from adult hippocampus develop essential properties of functional CNS neurons. Nat. Neurosci.5(5),438–445 (2002).
- 12 Bianco P, Riminucci M, Gronthos S, Robey PG: Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells19(3),180–192 (2001).
- 13 Seidlits SK, Lee JY, Schmidt CE: Nanostructured scaffolds for neural applications. Nanomed.3(2),183–199 (2008).
- 14 Langer R, Vacanti JP: Tissue engineering. Science260(5110),920–926 (1993).
- 15 Sipe JD: Tissue engineering and reparative medicine. Ann. NY Acad. Sci.961,1–9 (2002).
- 16 Bozkurt A, Deumens R, Beckmann C et al.: In vitro cell alignment obtained with a schwann cell enriched microstructured nerve guide with longitudinal guidance channels. Biomaterials30(2),169–179 (2009).
- 17 Nisbet DR, Yu LM, Zahir T, Forsythe JS, Shoichet MS: Characterization of neural stem cells on electrospun poly(ε-caprolactone) submicron scaffolds: evaluating their potential in neural tissue engineering. J. Biomater. Sci. Polym. Ed.19(5),623–634 (2008).
- 18 Jain A, Kim YT, Mckeon RJ, Bellamkonda RV: In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials27(3),497–504 (2006).
- 19 Bongso A, Richards M: History and perspective of stem cell research. Best Pract. Res. Clin. Obstet. Gynaecol.18(6),827–842 (2004).
- 20 Moller MS: Human embryonic stem cell research, justice, and the problem of unequal biological access. Philos. Ethics Humanit. Med.3,22 (2008).
- 21 Nandedkar T, Narkar M: Stem cell research: its relevance to reproductive biology. Indian J. Exp. Biol.41(7),724–739 (2003).
- 22 Fu YS, Cheng YC, Lin MY et al.: Conversion of human umbilical cord mesenchymal stem cells in wharton’s jelly to dopaminergic neurons in vitro: potential therapeutic application for parkinsonism. Stem Cells24(1),115–124 (2006).
- 23 Yang J, Lou Q, Huang R, Shen L, Chen Z: Dorsal root ganglion neurons induce transdifferentiation of mesenchymal stem cells along a schwann cell lineage. Neurosci. Lett.445(3),246–251 (2008).
- 24 Yanjie J, Jiping S, Yan Z, Xiaofeng Z, Boai Z, Yajun L: Effects of notch-1 signalling pathway on differentiation of marrow mesenchymal stem cells into neurons in vitro. Neuroreport18(14),1443–1447 (2007).
- 25 Bae JS, Furuya S, Shinoda Y et al.: Neurodegeneration augments the ability of bone marrow-derived mesenchymal stem cells to fuse with purkinje neurons in niemann-pick type C mice. Hum. Gene Ther.16(8),1006–1011 (2005).
- 26 Cho KJ, Trzaska KA, Greco SJ et al.: Neurons derived from human mesenchymal stem cells show synaptic transmission and can be induced to produce the neurotransmitter substance P by interleukin-1α. Stem Cells23(3),383–391 (2005).
